Vicapsys Life Sciences, Inc. (VICP)

USD 7.0

(0.0%)

Total Assets Summary of Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.'s latest annual total assets in 2023 was 39.65 Thousand USD , down -44.94% from previous year.
Vicapsys Life Sciences, Inc.'s latest quarterly total assets in 2023 Q1 was 63.29 Thousand USD , down -12.12% from previous quarter.
Vicapsys Life Sciences, Inc. reported annual total assets of 72.02 Thousand USD in 2022, down -87.88% from previous year.
Vicapsys Life Sciences, Inc. reported annual total assets of 594.31 Thousand USD in 2021, up 47.06% from previous year.
Vicapsys Life Sciences, Inc. reported quarterly total assets of 378.14 Thousand USD for 2023 Q2, up 497.45% from previous quarter.
Vicapsys Life Sciences, Inc. reported quarterly total assets of 63.29 Thousand USD for 2023 Q1, down -12.12% from previous quarter.

Annual Total Assets Chart of Vicapsys Life Sciences, Inc. (2023 - 2008)

Historical Annual Total Assets of Vicapsys Life Sciences, Inc. (2023 - 2008)

Year	Total Assets	Total Assets Growth
2023	39.65 Thousand USD	-44.94%
2022	72.02 Thousand USD	-87.88%
2021	594.31 Thousand USD	47.06%
2020	404.11 Thousand USD	-42.14%
2019	698.43 Thousand USD	-12.29%
2018	796.33 Thousand USD	-26.05%
2017	1.07 Million USD	0.0%
2009	2.23 Million USD	108.65%
2008	1.06 Million USD	0.0%

Year	Total Assets	Total Assets Growth
2023 Q4	39.65 Thousand USD	-80.98%
2023 Q2	378.14 Thousand USD	497.45%
2023 Q1	63.29 Thousand USD	-12.12%
2023 Q3	208.48 Thousand USD	-44.87%
2022 Q4	72.02 Thousand USD	-81.23%
2022 Q3	383.8 Thousand USD	0.42%
2022 Q1	478.19 Thousand USD	-19.54%
2022 Q2	382.2 Thousand USD	-20.07%
2022 FY	72.02 Thousand USD	-87.88%
2021 Q4	594.31 Thousand USD	7.63%
2021 FY	594.31 Thousand USD	47.06%
2021 Q3	552.17 Thousand USD	-1.82%
2021 Q2	562.4 Thousand USD	31.28%
2021 Q1	428.4 Thousand USD	6.01%
2020 Q3	414.28 Thousand USD	-3.07%
2020 Q4	404.11 Thousand USD	-2.45%
2020 Q2	427.41 Thousand USD	-7.29%
2020 Q1	461.04 Thousand USD	-33.99%
2020 FY	404.11 Thousand USD	-42.14%
2019 Q3	950.27 Thousand USD	0.0%
2019 FY	698.43 Thousand USD	-12.29%
2019 Q4	698.43 Thousand USD	-26.5%
2019 Q1	- USD	-100.0%
2018 Q4	796.33 Thousand USD	0.0%
2018 FY	796.33 Thousand USD	-26.05%
2017 FY	1.07 Million USD	0.0%
2010 Q2	9.19 Million USD	717.55%
2010 Q1	1.12 Million USD	50343.46%
2009 Q4	2230.75 USD	0.0%
2009 FY	2.23 Million USD	108.65%
2008 FY	1.06 Million USD	0.0%

Peer Total Assets Comparison of Vicapsys Life Sciences, Inc.

Name	Total Assets	Total Assets Difference
America Great Health	299.12 Thousand USD	86.743%
Gene Biotherapeutics, Inc.	- USD	-Infinity%
Evolutionary Genomics, Inc.	2.35 Million USD	98.315%
Innovation1 Biotech Inc.	75.99 Thousand USD	47.816%
Point of Care Nano-Technology, Inc.	124.64 Thousand USD	68.184%